Abstract
Chilblain-like lesions (CLL) have been extensively reported during Coronavirus Disease-19 (COVID-19) pandemic in March-April 2020.1 While the link between these lesions and Severe Acute Respiratory Coronavirus 2 (SARS-Cov-2) is still unclear2, emerging evidences of “long COVID”, with extra cutaneous COVID-19 symptoms persisting over 60 days, are reported.3 The aim of this study was to assess the evolution of the CLL overtime. We performed a retrospective study to evaluate the frequency and the characteristics of CLL relapses and the persistence of other cutaneous symptoms. In January 2021, a survey was sent to 132 patients who were addressed to the dermatology department of Saint-Louis hospital, Paris between March 1st and April 30th 2020 for CLL lesions. Ninety-five answers were obtained.

This publication has 9 references indexed in Scilit: